pharmaceutical investing BioVie Reviews Key Accomplishments from 2017 and Updates Phase 2a Clinical Trial
Standard Uranium Retains 100% Unencumbered Ownership of the Sun Dog Project Through Conclusion of Property Option Agreement
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea